Core Viewpoint - New Oxygen (SY) experienced an 11.05% increase in stock price, reaching $4.12 per share, with a total market capitalization of $409 million as of August 20 [1] Financial Performance - As of June 30, 2025, New Oxygen reported total revenue of 676 million RMB, a year-over-year decrease of 6.84% [1] - The company recorded a net profit attributable to shareholders of -69.177 million RMB, reflecting a significant year-over-year decline of 2909.0% [1] Major Events - On August 19, New Oxygen received a maintained "Buy" rating from Haitong International, with the target price raised to $10.3 [1] - New Oxygen is focused on leveraging technology to assist women in enhancing their beauty and health, aiming to transform the opaque medical aesthetics market in China into a transparent one [1]

Group 1 - The stock price of Xinyang (SY) opened up by 6.42% on August 18, reaching $3.98 per share, with a total market capitalization of $395 million [1] - Financial data shows that as of March 31, 2025, Xinyang's total revenue was 297 million RMB, a year-on-year decrease of 6.6%, and the net profit attributable to shareholders was -33.138 million RMB, a year-on-year decrease of 56.02% [1] Group 2 - On August 15, Xinyang is scheduled to disclose its fiscal year 2025 mid-term report before the market opens (Eastern Time), with the actual disclosure date subject to company announcements [2] - Xinyang International is focused on leveraging technology to assist women in enhancing their beauty and health, aiming to transform the opaque medical aesthetics market in China into a transparent one, ultimately creating a one-stop platform for users to find quality services [2]